Search for: "Finnegan, Henderson, Farabow, Garrett, "
Results 1 - 20
of 309
Sort by Relevance
|
Sort by Date
14 Jan 2024, 9:15 pm
Sendil Devadas of Corteva Agriscience; Joshua Goldberg of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; and Kassandra Officer of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will discuss some of the most significant developments in PTAB practice in 2023 and how those developments will impact future cases, and discuss important decisions promulgated last year, including several designated precedential, as… [read post]
11 Jan 2024, 6:51 am
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, 473 Mass. 336 (2015), that the ‘critical inquiry’ in analyzing potential conflicts under the second prong of Rule 1.7 ‘is whether the lawyer has a competing interest or responsibility that will materially interfere with the lawyer’s independent professional judgment in considering alternatives or foreclose courses of action that reasonably should be pursued on behalf of the… [read post]
19 Mar 2023, 9:21 pm
Burgy of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on the issues surrounding Risk Evaluation and Mitigation Strategy (REMS) patents and listing in the Orange Book, discuss REMS patents and what patent prosecutors need to know, address the current efforts of the USPTO and FDA to... [read post]
4 Mar 2023, 8:45 pm
Irving of Finnegan Henderson Farabow Garrett & Dunner, Sarah Hooson of Merck Sharp & Dohme, Krista Kostiew of Unilever, and Xiaoguang Michelle Gao of Eli Lilly and Company will guide patent counsel on recent trends and developments in patent practice; examine the Supreme Court, Federal Circuit, and PTAB cases from the past year; and discuss some of the key developments and strategies.... [read post]
11 Feb 2023, 7:17 pm
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Sarah Hooson of Merck Sharp & Dohme will guide patent counsel on recent Orange Book developments; discuss Orange Book listing practices and the implications for patent prosecution, listing, and litigation; and examine contemporary thought about Form 3542 and pitfalls to avoid.... [read post]
5 Feb 2023, 9:11 pm
Antje Brambrink of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Jakob Kellenberger of Procter & Gamble; and Leo Steenbeek Koninklijke Philips N.V. will provide a high-level overview of the UPC system and shed some more light on the threats and opportunities of this new venue both from the perspective of industry and litigators. [read post]
28 Jan 2023, 8:09 pm
.; Sharonmoyee Goswami of Cravath, Swaine & Moore LLP; Derek McCorquindale of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; and Angelo Oliver of Haynes & Boone, LLP will review key decisions issued by the Federal Circuit regarding patent law issues in 2022, including decisions on enablement and written description, patent damages, venue, litigation procedure, and AIA trials before the Patent Trial and Appeal... [read post]
15 Jan 2023, 7:19 pm
Joshua Goldberg, Tom Irving, Sydney Kestle, Gracie Mills, and Trenton Ward of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will discuss some of the most significant developments in PTAB practice in 2022 and how those developments will impact future cases, important precedent promulgated last year, and Director Vidal's impact on the PTAB during 2022, including a summary of those cases where Director Review was granted. [read post]
4 Jan 2023, 9:41 am
In this webinar, Amanda Murphy and Darren Jiron of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will provide an overview of post-grant challenges and procedures in the U.S. [read post]
2 Jan 2023, 9:34 pm
Raich, and Yieyie Yang of Finnegan Henderson Farabow Garrett & Dunner will guide attendees on the Biologics Price Competition and Innovation Act (BPCIA), discuss the Purple Book and issues related to exclusivities and the retroactivity of the BPCIA, address the ongoing debate over whether the BPCIA's patent dispute resolution procedures are allowed or required and the litigation that... [read post]
27 Dec 2022, 6:38 pm
Irving of Finnegan Henderson Farabow Garrett & Dunner, and Angela Sebor of Tolmar will guide attendees on patenting drug formulations from drafting through patent prosecution and enforcement, examine lessons learned from the case law, and offer strategies to overcome the potential challenges. [read post]
2 May 2022, 2:43 pm
In an IP battle between "heavy-weight" law firms Sidley Austin LLP, (for appellant) and Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (for appellee), the appellant Auris Health prevailed against patentee in a "motivation to combine" case. [read post]
2 Apr 2022, 8:31 pm
Azra Hadzimehmedovic of Tensegrity Law Group will moderate a panel consisting of Lauren Kindler of Analysis Group; Chris Longman of Qualcomm; Andrew Parolin of Wi-LAN; Jason Romrell of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; and Chris Storm of Uber. [read post]
26 Feb 2022, 7:46 pm
Thayer of Finnegan Henderson Farabow Garrett & Dunner will assist patent practitioners in drafting high quality patent applications for machine learning inventions, and discuss different claim styles and framings that may be appropriate for different machine learning inventions, how to anticipate and minimize the risks of §§... [read post]
19 Feb 2022, 8:38 pm
Sommer of Greenberg Traurig, LLP will moderate a panel consisting of Sharonmoyee Goswami of Cravath, Swaine & Moore LLP; Derek McCorquindale of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Angelo Oliver of Haynes & Boone, LLP; and Jill Schmidt of Genentech, Inc. [read post]
12 Feb 2022, 6:55 pm
Williamson of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will address how companies can adapt and contain the legal risk while guarding the integrity of the information entrusted to their employees. [read post]
29 Jan 2022, 7:36 pm
Puknys of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel consisting of Peter Marksteiner, Circuit Executive and Clerk of Court, U.S. [read post]
15 Jan 2022, 8:41 pm
Tom Irving, Mark Feldstein, and Joshua Goldberg of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Jessica Marks of Unified Patents; and Nichole Valeyko of Merck & Co. will highlight important PTAB decisions from 2021, as well as impacts on PTAB practice from external sources such as the Supreme Court, Federal Circuit, and Congress, and what to watch out for in 2022. [read post]
31 Oct 2021, 9:10 pm
Sabine Age of Hoyng Rokh Monegier will moderate a panel consisting of Patrick Coyne of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; Kevin Duan of Han Kun Law; Dina Kallay of Ericsson; Bill MacLeod of Kelley Drye & Warren LLP; and Barry Nigro of Fried, Frank, Harris, Shriver & Jacobson LLP. [read post]
31 Oct 2021, 9:00 pm
Sandonato of Venable I Fitzpatrick will moderate a panel consisting of Paul Browning of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; Nakajima Masaru of Seiwa Patent & Law; Jason Mueller-Neuhaus of Borden Ladner Gervais LLP; and Anne Schön of Hoffmann Eitle. [read post]
